Cream for dry, itchy skin from cancer therapy
Part of Cancer, Skin clinical trials.
This study tests a moisturizing cream (with pre- and postbiotics and niacinamide) to see if it reduces dryness and itching in cancer patients who are on a type of targeted therapy called anti-EGFR drugs. If you have dry, itchy skin from your treatment, this cream might help soothe it.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need to be on an anti-EGFR cancer therapy (like cetuximab or panitumumab) for at least 3 months.
- You should not have a moderate to severe acne-like rash on your face or chest from your treatment.
- You must not be using any other moisturizers or steroid creams on the affected skin right now.
- You cannot have had a chronic dry-skin condition (like lichen or ichthyosis) or an itchy problem of unknown cause in the past.
- You must be able to give your informed consent and follow the study procedures.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests a topical cream (HT-001) to treat skin rashes caused by EGFR inhibitors. It aims to see whether the cream is safe and can reduce rash symptoms and discomfort.
This study tests a special cream that may prevent skin irritation (radiation dermatitis) caused by radiation therapy for breast cancer. The cream is made from natural weak acids and aims to protect the skin by keeping the skin's microbiome healthy.
This study tests a new cream, ATR04-484, to see if it can help with skin rashes caused by certain cancer medications (EGFR inhibitors, KRAS inhibitors, or MEK inhibitors). If you have a moderate to severe rash on your face or other areas from these drugs, this trial may offer a new way to ease your symptoms.
This study tests whether using two cosmetic products together helps relieve dry and itchy skin in people with sensitive skin. If you qualify, you may get a new skin care routine that could reduce itching and improve your skin's moisture.
This study looks at how different moisturizers affect skin changes in people with cancer who are experiencing side effects from their treatment. It aims to find which moisturizer works best for managing these skin issues.
This trial tests a new type of cream made with tiny particles that mop up harmful molecules to prevent or treat skin damage from radiation. It is for people with head or neck cancer receiving high-dose radiation to see if it can reduce skin redness, pain, and peeling.
Hear when a new Xerosis Cutis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.